Centene Reports $253 Million Loss Amid Health Insurer Cost Struggles
Health insurer Centene reported a $253 million loss in its second quarter as the provider of government-subsidized benefits struggles to manage costs of its health plan members.
Centene reports a rare loss as medical costs surge, and the stock hits a decade low
Centene's stock extends its record monthly selloff after the health insurer reported a surprise quarterly loss as benefit payouts exceed expectations.
Centene Stock Plummets. The Health Insurer's Results Were Even Worse Than Feared.
The company reported a surprise quarterly loss, the latest blow for the embattled health insurance industry.
Health insurer Centene reports surprise quarterly loss
Centene on Friday reported a surprise quarterly loss after the health insurer warned of a revenue slump from government-backed plans, sending its shares down nearly 3% in premarket trading.
Bear of the Day: Centene (CNC)
Centene Corporation ( CNC ), a giant of managed care expected to cross $175 billion in revenues this year, unexpectedly pulled its earnings guidance for 2025 on July 2. This change came after an unexpected shift in the dynamics of the health Insurance Marketplace, which could impact earnings more significantly than what was initially forecasted.
Will Escalating Medical Costs Dampen Centene's Q2 Earnings?
CNC's Q2 earnings are likely to have felt the pinch as rising medical costs pressure margins despite higher premium revenues.
Unveiling Centene (CNC) Q2 Outlook: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Centene (CNC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Centene: The Cheapest Insurer I've Ever Seen
CNC is trading at half of book value and under 9x earnings, an extreme undervaluation for a cash-generating insurer. The recent guidance cut is a temporary earnings reset, not a structural issue -- premium increases and cost controls will restore margins as per standard industry cycles. Market panic and mechanical selling have created a rare value opportunity; insurance fundamentals and rate adjustments ensure earnings normalization over time.
Analysts Estimate Centene (CNC) to Report a Decline in Earnings: What to Look Out for
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Centene: Buy Signals Emerge After Capitulation-Like Sell-Off
Centene's stock plunged after withdrawing 2025 guidance due to higher medical costs, but the selloff appears to be a capitulation event. The stock is deeply oversold, trading at just 10x reduced 2025 earnings, with a strong balance sheet and potential for a sharp rebound in 2026-2027. Challenges include Medicaid cuts and higher-risk policyholders, but corrective pricing actions and sector defensiveness in a recession offer upside.
Centene Stock Down 40% — May Slide On $1 Trillion Medicaid Cuts
The Big Beautiful Bill Act cuts $1 trillion from Medicaid from which Centene gets 58% of its revenue. After plunging 40% will the stock drop more?
Healthcare Hit Again: Molina Cuts Guidance, Echoing Centene and UNH
MOH slashes 2025 EPS outlook by more than 10%, citing rising medical costs and echoing warnings from CNC and UnitedHealth.
